AMGEN INC is 23.8x more valuable than QIAGEN N.V. by market capitalization ($191.70 B vs $8.04 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | QGEN | AMGN |
|---|---|---|
| Market cap | $8.04 B | $191.70 B |
| US-listed rank | #1085 | #79 |
| Revenue (latest FY) | $2.09B | $36.75B |
| Net income (latest FY) | $424.88M | $7.71B |
| Net margin | 20.3% | 21.0% |
| P/E (trailing FY) | 18.9 | 24.9 |
| SEC filings | 471 | 1,011 |
AMGEN INC is 23.8x more valuable than QIAGEN N.V. by market capitalization ($191.70 B vs $8.04 B).
In their latest fiscal years, QIAGEN N.V. reported $2.09B in revenue while AMGEN INC reported $36.75B.
Full pages: QIAGEN N.V. and AMGEN INC, or browse the full rankings.